Resolution of Chlamydia genital tract infection is delayed in the absence of MyD88. In these studies, we first used bone marrow chimeras to demonstrate a requirement for MyD88 expression by hematopoietic cells in the presence of a wild-type epithelium. Using mixed bone marrow chimeras we then determined that MyD88 expression was specifically required in the adaptive immune compartment. Furthermore, adoptive transfer experiments revealed that CD4 + T cell expression of MyD88 was necessary for normal resolution of genital tract infection. This requirement was associated with a reduced ability of MyD88 2/2 CD4 + T cells to accumulate in the draining lymph nodes and genital tract when exposed to the same inflammatory milieu as wild-type CD4 + T cells. We also demonstrated that the impaired infection control we observed in the absence of MyD88 could not be recapitulated by deficiencies in TLR or IL-1R signaling. In vitro, we detected an increased frequency of apoptotic MyD88 2/2 CD4 + T cells upon activation in the absence of exogenous ligands for receptors upstream of MyD88. These data reveal an intrinsic requirement for C hlamydia trachomatis infections of the female reproductive tract can result in serious pathophysiology including pelvic inflammatory disease, chronic pelvic pain, ectopic pregnancy, and infertility (reviewed in Ref. 1) . The immune response to Chlamydia is dually responsible for resolution of infection and the development of genital tract pathology. Because of its obligate intracellular lifecycle, Chlamydia is able to evade innate defense mechanisms that are effective against extracellular bacteria, and innate immune responses have been repeatedly correlated with the development of oviduct pathology (2) (3) (4) (5) (6) . In contrast, studies in the mouse model have revealed that the adaptive immune response is crucial for eradication of both primary (7) and secondary infection (8) . In addition, CD4 + Th1 cells are crucial for protection in both mice (8) (9) (10) (11) (12) (13) and women (14) (15) (16) . CD4 + T cells directly interact with infected epithelial cells and promote eradication of infection via IFN-g-dependent and -independent mechanisms (11, 12, 17, 18) .
Recognition of pathogens by pattern recognition receptors expressed by innate immune cells is crucial for effective induction of an adaptive immune response (19) , but overly robust innate immune activation results in tissue damage. Chlamydiae stimulate several pattern recognition receptors including TLR2 (5, 20) , TLR3 (21) , TLR4 (22, 23) , and nucleotide-binding oligomerization domain-containing protein 1 (24) . Mice deficient in TLR2 develop reduced levels of oviduct pathology in response to Chlamydia muridarum infection, but resolution of infection is not impacted by the absence of this receptor (5) . TLR4 and nucleotide-binding oligomerization domain-containing protein 1 do not appear to play a central role in either tissue damage or induction of a protective immune response in the mouse model (5, 24) . These findings were corroborated by a study of women with Chlamydia trachomatis pelvic inflammatory disease, which revealed that women with specific polymorphisms in TLR1, a receptor that signals by forming heterodimers with TLR2 (25) , exhibited decreased rates of pregnancy, whereas no such association was found with polymorphisms in TLR4 (26) . A Dutch study found a nonsignificant association of the TLR4 +896 G allele with tubal factor infertility (27) .
MyD88 is an adaptor molecule that is central to signaling via all TLRs except for TLR3 and is required for signaling by the IL-1 family of cytokine receptors (28) (29) (30) (31) (32) . Recognition of ligands by these receptors induces conformational changes that promote homotypic interactions between the Toll/IL-1R (TIR) domain of these receptors and those of intracellular adaptor molecules including MyD88 (33) (34) (35) . Stabilized oligomers of MyD88 then interact via death domains with IL-1R-associated kinase (IRAK) 1, IRAK2, and IRAK4 to form a Myddosome complex (34, (36) (37) (38) (39) . This signal transduction cascade leads to NF-kΒ-and AP-1-mediated transcription of proinflammatory genes. MyD88 is thus central to promoting innate immune activation and has been implicated in promoting resistance to a multitude of pathogens in the mouse model (reviewed in Ref. 40) . In humans, loss-of-function mutations in MyD88 (41) and IRAK4 (42) have been associated with the development of severe and potentially fatal bacterial infections in children.
The importance of MyD88 in promoting adaptive immune responses to pathogens in murine models has been repeatedly attributed to its central role in innate immune activation. However, a requirement for MyD88 expression by adaptive immune cells has also been observed in models of infection and autoimmunity. In a murine model of Toxoplasma gondii infection, control of infection was impaired even when MyD88-deficient adaptive immune cells were activated in the presence of normal APCs (43) . These findings were recapitulated in two independent studies of murine lymphocytic choriomeningitis virus (LCMV) infection, which demonstrated that both CD4 + and CD8 + T cell survival was reduced in the absence of intrinsic expression of MyD88 (44, 45) . A requirement for MyD88 expression by CD4
+ T cells was also demonstrated in a model of colitis where MyD88-deficient CD4 + T cells exhibited reduced accumulation and cytokine production both in vitro and in vivo (46, 47) . Finally, a recent publication demonstrated that CD4 + T cell expression of MyD88 was required for Th17 differentiation and the development of experimental autoimmune encephalitis (48) . Although the precise mechanism(s) behind this requirement for MyD88 in adaptive immune cells has not been determined, receptors upstream of MyD88 have been implicated in direct costimulation of T cells (49) (50) (51) (52) (53) (54) .
MyD88-mediated signals promote cytokine production by innate immune cells in response to Chlamydia infection (5, 20, 55, 56) . In addition, MyD88 2/2 mice exhibit significantly impaired control of Chlamydia muridarum genital tract infection (55, 57, 58) . Prolonged infection was associated with early reductions in NK cell IFN-g production in the cervix and a decreased frequency of CD4 + T cells in the upper genital tract. However, Chlamydiaspecific CD4 + T cell proliferation and IFN-g production remained largely intact in the draining lymph nodes, although a small increase in IL-4 production was detected (58) .
The development of a vaccine against Chlamydia requires delineation of immune mechanisms of protection from those that cause pathology. Activation of receptors upstream of MyD88, including TLR2 (5) and IL-1R (59) , results in the development of oviduct damage in the mouse model. Although it is clear from these findings that MyD88-mediated signals promote tissue-damaging responses to chlamydial infection, detection of prolonged genital tract infection in MyD88 2/2 mice indicates that this molecule also participates in protective immunity. A rapid and robust CD4 + T cell response is key for control of chlamydial infection and protection from disease (10, 60, 61) , and MyD88 expression by adaptive immune cells has been implicated in promoting optimum responses in other models (43, (45) (46) (47) . However, these studies used models of systemic infection, and an intrinsic requirement for MyD88 in adaptive immune cells has not been previously explored in a model of mucosal infection. Using bone marrow chimeric mice and CD4 + T cell adoptive transfer experiments, we have determined that intrinsic expression of MyD88 in CD4 + T cells is required for accumulation of CD4 + T cells in infected tissues and efficient resolution of Chlamydia genital tract infection. In vitro and in vivo experiments suggest that the CD4 + T cell specific effects of MyD88 are independent of TLR or IL-1R activation.
Materials and Methods
Strains, cell lines, and culture conditions C. muridarum Nigg was used for all experiments and was isolated as described previously (62, 63) . All chlamydial strains were propagated in L929 cells (64) . Bacteria were titrated by plaque assay (63) or as inclusion forming units (IFU) using fluorescently tagged antichlamydial LPS mAb (Bio-Rad, Hercules, CA) (65) . 
Murine infection and monitoring
Female mice of at least 6 wk of age were s.c. injected with 2.5 mg medroxyprogesterone (Depo-Provera; Upjohn, Kalamazoo, MI) 5-7 d prior to infection to induce a state of anestrous (68) . Mice were intravaginally inoculated with 1 3 10 5 IFU C. muridarum Nigg diluted in 30 ml sucrosesodium phosphate-glutamic acid buffer unless otherwise indicated. Mice were monitored for cervicovaginal shedding via endocervical swabs (69) , and IFUs were calculated as described previously (65) . Bacterial burden was measured in the oviducts, lungs, liver, and spleen by plaque assay (63) . C57BL/6 mice were used as controls for all strains of knockout mice, except TLR3 2/2 mice, which are on a mixed C57BL/6 and 129S background. Thus, F 2 hybrids of C57BL/6 and 129S mice were used as controls for those mice. 
Generation of bone marrow chimeras

Generation of mixed bone marrow chimeras
Recipient mice were fed antibiotic food (1.2% sulfamethoxazole and 0.2% trimethoprim; Lab Diet) and sterile acidified water (pH 2.5-3) for 10 d prior to irradiation. Recipient mice were treated with two doses of 450 rad (900 rad total) of X-ray irradiation separated by 6 h. Immediately after irradiation, Rag1 2/2 mice were reconstituted with 2. 
CD4
+ T cell transfer into Rag1 2/2 mice CD4 + T cells were isolated from the spleens of naive C57BL/6 or MyD88 2/2 mice by negative magnetic selection (CD4 + T cell isolation kit II; Miltenyi Biotec, Auburn, CA). The purity of CD4 + T cells was determined to be .93% for both strains by flow cytometry prior to transfer. Rag1 2/2 mice were injected i.v. with 4 3 10 6 CD4 + T cells from either strain. The frequency of CD4 + T cells in the peripheral blood was determined using flow cytometry at 3 wk after transfer. Mice were injected with Depo-Provera 4 wk after transfer and were infected with C. muridarum 5 wk after transfer. Data are presented from one representative experiment of three with five to six mice per group. Rag1 2/2 mice that did not receive a CD4 + T cell transfer were infected in three independent experiments with a total of 15 mice.
+ T cell cotransfer experiment mice (8 3 10 6 cells total) and infected intravaginally with 1 3 10 6 IFU C. muridarum Nigg. Four pools of cells per strain were processed independently from the beginning of the experiment and transferred into groups of three mice. The average purity of CD4 + T cells in these preparations was 88% for both strains of mice. Ten days postinfection, mice were euthanized, and single-cell suspensions were generated from their genital tracts and iliac nodes. The cervix and uterine horns were treated with collagenase I (1 mg/ ml; Sigma-Aldrich, St. Louis, MO), whereas the oviducts and iliac lymph nodes were mechanically disrupted using the previously described protocol (6, 70) . Cells from the cervix, uterine horns, and oviducts were pooled for analysis. Donor-derived cells were enriched using a CD90. 
In vitro analysis of CD4 + T cell apoptosis
Naive CD4 + T cells were isolated from the spleens of MyD88 2/2 (CD45.2) and WT (CD45.1) mice via negative magnetic selection (Mouse Naive CD4 + T cell isolation kit; StemCell Technologies, Vancouver, BC, Canada). Isolated T cells were combined at a 1:1 ratio (1 3 10 5 cells per strain) in a 96 well plate in complete medium. Complete medium consisted of DMEM (Thermo Fisher Scientific, Pittsburgh, PA), 10% FBS (Thermo Scientific Hyclone, Pittsburgh, PA), vancomycin (100 mg/ml; SigmaAldrich), gentamicin (50 mg/ml; Life Technologies, Grand Island, NY), glutamax (1 mg/ml; Life Technologies), 2-ME (50 mM; Sigma-Aldrich), and nonessential amino acids (0.5 mg/ml; Life Technologies). Cells were incubated with the indicated combination of the following reagents: platebound anti-CD3 (1 mg/ml, clone 145-2C11; eBioscience, San Diego, CA), soluble anti-CD28 (1 mg/ml, clone 37.51; BioLegend, San Diego, CA), IL-2 (5 ng/ml; PeproTech, Rocky Hill, NJ), IL-12p70 (10 ng/ml; PeproTech), and anti-IL-4 (1 mg/ml; clone 11B11; eBioscience). After 3 d in culture, cells were either directly stained for flow cytometry or were transferred to a new 96-well plate and incubated with complete medium without any stimulatory reagents for an additional 24 h prior to Ab staining. Surface staining was conducted using the following Ab combination: anti-TCR b-chain V450 (clone H57-597), anti-CD4 PE-Cy7 (clone RM4-5), anti-CD45.2 allophycocyanin (clone 104), and anti-CD25 PE (clone PC61). After surface staining, apoptosis was measured by staining with Annexin V-FITC according to the manufacturer's instructions (Annexin V-FITC Apoptosis Detection Kit I). Approximately 10 min prior to analysis, 5 ml 7-aminoactinomycin D (7-AAD) was added to the samples. All Abs and reagents used for staining were from BD Biosciences. Apoptosis was analyzed by gating on CD4 +   CD25 high T cells that were CD45.2 + (MyD88
2 (WT). Data shown represent the mean 6 SEM of triplicate wells for each condition from one representative experiment of two.
Statistics
Comparison of the course of infection was conducted via two-way repeated measures (RM) ANOVA with Bonferroni posttest analysis. A log-rank (Mantel-Cox) Test was used to compare the duration of infection. Significant differences in the frequency of cells accumulating in the genital tract and lymph nodes in the T cell cotransfer experiment were determined via MannWhitney U test. Apoptosis was compared between strains under different stimulatory conditions in vitro by two-way ANOVA with Bonferroni posttest analysis. Prism software (GraphPad Software, La Jolla, CA) was used for all statistical analysis. A p value , 0.05 was considered significant.
Results
MyD88 is required in hematopoietic cells for normal resolution of Chlamydia muridarum genital tract infection
Epithelial cells represent the primary niche for Chlamydia in the genital tract (71-73), and MyD88 participates in Chamydia-induced cytokine production by these cells (20, 56) . We first sought to determine whether the prolonged infection detected in the absence of MyD88 (55, 57, 58) could be observed for mice with a MyD88-deficient hematopoietic compartment and a WT epithelium. Bone marrow chimeras can be used for this purpose because hematopoietic cells are more sensitive to irradiation than epithelial or stromal cells. After irradiation, the hematopoietic compartment can be reconstituted with bone marrow from a donor strain of mice, whereas the epithelium retains the genotype of the recipient strain. WT 
MyD88 expression by adaptive immune cells is required for normal resolution of C. muridarum genital tract infection
MyD88-mediated signals promote activation of innate immune cells in response to C. muridarum (5, 55) . In addition, MyD88 expression by adaptive immune cells has been shown to be important in murine models of infection and autoimmunity (43) (44) (45) 76) . We sought to determine whether there was a role for MyD88 in promoting resolution of chlamydial infection in mice with a WT APC compartment and MyD88 deficiency solely in the adaptive immune cells. To this end, we generated mixed bone marrow chimeras based on the experimental design used by LaRosa et al. (43 bone marrow as another positive control ( Fig. 2A, 2B ) because of the central role for IFN-g signaling at the level of the genital tract epithelium (12, 13, 17, 70, 77 (Fig. 2C ). These data show that IFN-g production by innate
immune cells is crucial during the early days of infection, whereas MyD88 expression and IFN-g production by adaptive immune cells are required later.
MyD88 expression by CD4 + T cells is required for normal resolution of C. muridarum genital tract infection
The mixed bone marrow chimera experiment (Fig. 2) (Fig. 3A, 3B) T cells, it was day 47 (Fig. 3B) . However, Rag1 2/2 mice that did not receive a T cell transfer shed high levels of bacteria until they began to exhibit symptoms of systemic illness including tachypnea, hunching, lethargy, and death between days 14 and 25 postinfection (Fig. 3C ). This was observed in a total of 15 mice from three independent experiments. A group of moribund Rag1 2/2 mice was sacrificed on day 25 postinfection, and Chlamydia was detected in the oviducts, lungs, liver, and spleen (Fig. 3D) . Thus, although clearance of infection was impaired in the absence of MyD88 in CD4 + T cells, infection eventually resolved, and dissemination of infection was prevented.
Accumulation of MyD88
2/2 CD4 + T cells is impaired relative to WT CD4 + T cells
After demonstrating a role for MyD88 in CD4 + T cells in resolution of C. muridarum infection (Fig. 3) , we sought to define the mechanism responsible for this requirement. MyD88-mediated signals have been implicated in the survival of CD4 + and CD8
+ T cells in other models of infection (43-45). To determine whether MyD88
2/2 CD4 + T cells exhibited impaired accumulation in the genital tract and iliac nodes when exposed to the same inflammatory milieu as WT CD4 + T cells, we conducted a cotransfer experiment where a 1:1 ratio of MyD88 2/2 and WT CD4 + T cells was transferred into immunologically normal mice expressing a disparate allele of CD90 (CD90.1 + ) (Fig. 4A ). Mice were intravaginally infected with C. muridarum at the time of T cell transfer. By day 10 postinfection, there was a significantly decreased frequency of MyD88
CD4
+ T cells in both the iliac lymph nodes and genital tract (Fig. 4B) . This difference was particularly striking in the genital tract where an average of 74% of donor cells were from the WT donor (Fig. 4B-E (Fig. 4B ) exposed to the same inflammatory milieu indicated that a MyD88-mediated signal might act to directly costimulate T cells during chlamydial infection. Signaling through several TLRs including TLR2 (49), TLR3 (50), TLR4 (51), TLR5 (52), TLR7 (52) , and TLR9 (50) has been observed to directly costimulate T cells and promote their survival. We sought to determine if a deficiency in any of these receptors could recapitulate the significantly prolonged infection we observed in the absence of MyD88. We have previously observed that mice deficient in TLR2 or TLR4 resolve infection from the lower genital tract normally (5). We next infected mice deficient in both TLR2 and TLR4 to determine whether these receptors served redundant roles; however, infection resolved with normal kinetics in the absence of both of these receptors (Fig. 5A) . Although TLR3 signaling is not MyD88 dependent, we sought to determine whether TLR3-mediated signals could promote resolution of infection because polyinosinic-polycytidylic acid can promote the survival of CD4 + T cells (Fig. 5B ) (50), and Chlamydia has been demonstrated to stimulate TLR3 (79) . Resolution of infection from mice deficient in TLR3 was normal. Bacteria in lysosomes have been shown to stimulate TLR7 (80), but we determined that TLR7 was not required for normal resolution of infection (Fig. 5C) . Chlamydia possesses unmethylated deoxycytidylphosphate-deoxyguanosine (CpG) dinucleotides (81), which represent potential ligands for TLR9 (67) . However, TLR9
2/2 mice also resolved infection normally (Fig. 5D ). The role of TLR5 was not examined because Chlamydiae are nonmotile bacteria that do not express flagellin. MyD88 is also required for signaling via the IL-1 family of cytokine receptors, which includes receptors for IL-1, IL-18, and IL-33. Mice deficient in the IL-1R exhibit an increased bacterial burden in the lower genital tract, but infection is not significantly prolonged relative to WT mice (59) . We have observed that IL-18-deficient mice resolve infection from the genital tract normally (data not shown), which is in agreement with the normal resolution of infection observed in NLRP3 2/2 mice that have significantly impaired IL-18 production in response to Chlamydia (59). Finally, we did not pursue evaluation of IL-33-deficient mice because IL-33 induces Th2 responses and is not likely to promote resolution of chlamydial infection (32).
MyD88-deficient cells exhibit impaired survival upon activation in vitro
Our in vivo data indicate that deficiencies in receptors upstream of MyD88 do not recapitulate the phenotype of MyD88 2/2 mice (Fig. 5) . These findings are similar to what has been described in other murine models (43, 45) . We then sought to determine whether impaired accumulation of MyD88 2/2 T cells would occur in vitro in the absence of TLR or IL-1R agonists, supporting the hypothesis that the accumulation defect observed in vivo (Fig. 4B) was independent of receptors upstream of MyD88. Naive CD4
2 ) were isolated from the spleens of MyD88 2/2 (CD45.2) and WT (CD45.1 + ) mice. These cells were mixed at a 1:1 ratio and stimulated in vitro with different combinations of the following reagents: anti-CD3 (1 mg/ml), anti-CD28 (1 mg/ml), IL-2 (5 ng/ml), IL-12p70 (10 ng/ml), and anti-IL-4 (1 mg/ml) (Fig. 6) . A coculture of MyD88 2/2 and WT T cells was performed to prevent confounding effects that could result from differences in the inflammatory milieu. After 3 d in culture, activated T cells (CD25 + ) were either examined for their viability based on annexin V and 7-AAD staining or were removed from culture and replated for an additional 24 h with media alone prior to analysis of apoptosis. After 3 d and 3 d plus 24 h rest, the level of CD25 expression by CD25 + CD4 + T cells did not differ between the strains (Fig. 6A, 6B) . However, the frequency of apoptotic (AnnexinV + 7AAD 2 ) CD4 + CD25 + T cells was significantly increased in the absence of MyD88 under all stimulatory conditions tested (Fig. 6C, 6E, 6F) . After an additional 24 h without stimulation, there was no longer a difference in the frequency of apoptotic cells in the group that had been stimulated with anti-CD3 alone, but the frequency of apoptotic cells was significantly increased in the absence of MyD88 under all other stimulatory conditions (Fig. 6D) . The frequency of cells from either strain that upregulated CD25 upon incubation with media alone for 3 d was negligible, so that group was not included in analysis of apoptosis. These data indicate that activated MyD88-deficient CD4 + T cells have an increased propensity toward apoptosis even in the absence of exogenous TLR/IL-1R ligands.
Discussion
In this paper, we present the results of our studies examining the role of the adaptor molecule MyD88 in the development of an effective adaptive immune response to Chlamydia genital tract infection. In doing so we attempt to provide a mechanism for the significantly impaired resolution of infection previously observed in MyD88-deficient mice (55, 57, 58) . The increased bacterial burden observed in the absence of MyD88 was associated with the development of severe oviduct pathology (57, 58), which indicated that MyD88-dependent signaling was a double-edged component of the immune response to Chlamydia genital tract infection. Mice deficient in receptors upstream of MyD88, including TLR2 knockout mice (5) and IL-1R-knockout mice (59), exhibit significantly reduced oviduct pathology. However, signaling via MyD88 is necessary to effectively control infection and prevent the tissue damage that can result from a significantly increased bacterial burden. The goal of the studies outlined in this paper was to determine whether the role of MyD88 in promoting the adaptive immune response could be separated from its involvement in promoting tissue damaging innate immune responses.
We first explored whether the prolonged infection observed in the absence of MyD88 could at least partially be attributed to a lack of MyD88 in circulating hematopoietic cells. We determined that bone marrow chimeras with a MyD88-deficient hematopoietic compartment and wild-type epithelial/stromal cells did indeed exhibit a significantly prolonged infection. Although the role of MyD88 in enhancing innate and adaptive responses to Chlamydia would seem intuitive, it was important to rule out the possibility that a deficiency in MyD88 expression by the epithelium of the genital tract was required to observe impaired resolution of infection. In vitro experiments have shown that genital tract epithelial cells produce significantly lower levels of cytokines in response to Chlamydia in the absence of MyD88 (56) . In addition, MyD88 can directly interact with the IFNgR (82), which could be important in IFN-g-mediated clearance of Chlamydia from epithelial cells. The significantly prolonged infection we observed for the bone marrow chimeras in the presence of a wild-type epithelium pointed to an important role for MyD88 expression by circulating immune cells, although it did not exclude the possibility that MyD88 signaling at the level of the epithelium participated in controlling infection.
An important technical point regarding the use of bone marrow chimeras in this model is that X-ray irradiation can influence the architecture of the genital tract. We observed that the bacterial burden in the lower genital tract of irradiated mice was 10-to 100-fold lower than that of non-irradiated mice at the peak of infection. In addition, at the time of sacrifice, the uterine horns and cervices of mice that had been irradiated where significantly thinner than those of nonirradiated mice. These effects may preclude the use of this type of experiment in describing immune mediators of genital tract pathology. It also prevented us from analyzing mice with a MyD88-deficient epithelium because these mice exhibit a further increase in susceptibility to radiation-induced damage because of a higher proliferative rate of epithelial cells (74) . Despite these caveats, we determined that mice with MyD88-deficient hematopoietic cells exhibited a prolonged course of infection similar to that observed in MyD88 2/2 mice. These findings indicated that MyD88-mediated signals that directly promote epithelial damage, as has been described for IL-1 in vitro (83), could potentially be separated from MyD88-mediated responses essential for normal resolution of infection. To directly examine the role of MyD88 in the genital tract epithelium, a murine strain with a MyD88 deficiency solely in these epithelial cells, as has been described for epithelial cells of the gastrointestinal tract, will be required (84) . We next used mixed bone marrow chimeras to more specifically explore the role of MyD88 in promoting clearance mediated by hematopoietic cells, with a focus on MyD88 expression by adaptive immune cells. The mixed bone marrow chimera experimental design was based on a previous paper, which showed that MyD88 expression by adaptive immune cells was required for control of Toxoplasma gondii infection (43) expression of MyD88 may be required for an optimal T cell IFN-g response in the genital tract. However, this is not likely due to a decreased ability of MyD88-deficient CD4 + T cells to differentiate into Th1 cells because that has been repeatedly demonstrated to be unimpaired both in vitro and in the presence of normal APCs in vivo (45, 46, 48) .
We used a CD4 + T cell transfer model to confirm our suspicions that MyD88 expression by CD4 + T cells was necessary for eradication of Chlamydia from the genital tract, because CD4 + T cells are the only adaptive immune cells required for clearance of primary infection in this model (10) (45) . Similar results were obtained upon transfer of LCMV-specific MyD88-deficient and WT CD8 + T cells into WT recipients, and the detection of a significantly reduced number of MyD88-deficient CD8 + T cells responding to LCMV was associated with an increased rate of apoptosis and not a defect in proliferation (45) . This would explain why we previously observed normal proliferation of Chlamydia-specific CD4 + T cells in from the iliac lymph nodes of MyD88 2 /2 mice but a reduced frequency of these cells in the genital tract in the presence of a dramatically increased bacterial burden (58) . We attempted to find a receptor upstream of MyD88 signaling that would explain the deficiencies we observed in its absence. Our current and former studies show that mice with deficiencies in TLR2 (5), TLR2 and TLR4 (current work), TLR4 (5), TLR7 (current work), TLR9 (current work), IL-1R (59), and IL-18R (current work) do not exhibit delayed resolution of infection. These negative data could indicate that an untested TIR domaincontaining receptor participates in MyD88-mediated control of infection or that a combination of deficiencies can explain this impaired resolution. However, it is also possible that MyD88 plays an unconventional role in promoting T cell survival. Our in vitro apoptosis assays were conducted without the addition of exogenous TLR/IL-1R ligands, and we still observed an increased rate of apoptosis in the absence of MyD88. Although we cannot rule out a role for autologous cytokine production or molecules released from dying cells in costimulating these cells, the fact that the level of CD25 expression by MyD88 2/2 and WT T cells was comparable under the stimulatory conditions tested, indicates that these cells were not exposed to different exogenous activating signals as would occur in the presence of signaling via mediators upstream of MyD88. Rather, these findings indicate that stimulatory signals are able to promote similar levels of activation in MyD88-deficient T cells, but defects arise after the divergence of activating and survival signals. This is similar to what was observed in a model of LCMV (45), where differentiation and activation of MyD88-deficient CD8 + T cells was normal, but accumulation was dramatically impaired. Interestingly, a number of MyD88-mediated signals that are TIR domain independent have been described such as a role for MyD88 in interacting with the IFN-gR (82), PI3K (85, 86) , Fas-associated death domain protein (FADD) (87, 88) , IFN regulatory factor (IRF)1 (89), IRF5 (89, 90) , and IRF7 (91) . FADD has been observed to prevent MyD88-mediated proinflammatory signals, so we could speculate that MyD88 could reciprocate by preventing FADD-mediated proapoptotic signals (92) . Our findings also indicate that the intrinsic requirement for MyD88 in CD4 + T cells for normal resolution of Chlamydia genital tract infection is not at specific to this model. That would explain why similar findings have been observed across several models without an upstream mechanism (43) (44) (45) .
We were unable to find a receptor upstream of MyD88 that was required for resolution of Chlamydia from the genital tract. Direct stimulation of MyD88-dependent receptors on CD4 + T cells does not significantly enhance protective immunity during chlamydial infection. In addition, activation of these pathways in CD4 + T cells has been shown to lead to detrimental responses in murine models, including induction of pathologic Th17 responses (48) , experimental autoimmune encephalitis (48) , and inflammatory bowel disease (46, 47) . These data indicate that activation of TLR and IL-1R on CD4 + T cells should not be incorporated into a vaccination strategy. In contrast, MyD88 augments the longevity of CD4 + T cells. In the absence of MyD88, small reductions in CD4 + T cell accumulation in the lymph nodes translate into dramatically decreased numbers of CD4 + T cells in the genital tract and impaired resolution of infection. Although the specific mechanisms whereby MyD88 promotes T cell longevity have not been determined, these studies show that MyD88 is clearly a necessary component of an effective adaptive immune response to Chlamydia. Determination of signaling pathways that promote CD4 + T cell survival would accelerate vaccine development.
